Clinical Trial

Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
To determine whether glucose fluctuations prior to antibiotic administration are associated with sepsis severity and poor clinical outcomes. * To assess if the time to Glycemic Normalization after Antibiotic Initiation can be used as an Early Prognostic Indicator in Sepsis. * To evaluate the Glycemic Shock Index (GSI) as a Combined Marker of Hemodynamic and Metabolic Stress in ICU Sepsis Patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-16.
Trial Details
NCT Number NCT07234526
Lead Sponsor Assiut University
Conditions Glucose Fluctuations in Sepsis
Enrollment 105 participants
Start Date 2026-12-01
Primary Completion 2028-12-01 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-19